However, studies in choriocarcinoma and breast cancer cells have demonstrated that a decrease in M6P/IGF2R expression enhances tumor cell growth [18,19], whereas overexpression of the receptor causes the opposite effect [20,21]. This evidence concerns the gene IGF2R and breast cancer.